INT79547

Context Info Confidence 0.17 First Reported 1998 Last Reported 1998 Negated 0 Speculated 0 Reported most in Abstract Documents 1 Total Number 1 Disease Relevance 0.89 Pain Relevance 0.17

Rmp3 (Mus musculus)

Pain Link Frequency Relevance Heat imagery 1 80.64 agonist 1 73.08 bradykinin 1 72.76 headache 1 61.12

Disease Link Frequency Relevance Heat Oligodendroglioma 1 82.72 Anaplastic Astrocytoma 1 81.44 Glioblastoma 1 80.40 Glioma 2 79.32 Cancer 1 76.00 Immunotherapy Of Cancer 1 69.76 Increased Venous Pressure Under Development 1 62.56 Vomiting 1 61.76 Headache 1 61.12 Heart Rate Under Development 1 59.68

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

Patients were allocated to one of five treatment regimes: cohort A (n = 2) received 50 ng/kg RMP-7 and target AUC 5 mg/ml/min carboplatin; cohort B (n = 3) 100 ng/kg RMP-7 + AUC 5; cohort C (n = 2) 100 ng/kg RMP-7 + AUC 7; cohort D (n = 2) 200 ng/kg RMP-7 + AUC 7; cohort E (n = 5) 300 ng/kg RMP-7 + AUC 7.

Regulation (target) of RMP-7

1) Confidence 0.17 Published 1998 Journal Eur. J. Cancer Section Abstract Doc Link 9893673 Disease Relevance 0.89 Pain Relevance 0.17

General Comments

This test has worked.